» Articles » PMID: 34601038

Cortical Alpha-synuclein Preformed Fibrils Do Not Affect Interval Timing in Mice

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2021 Oct 3
PMID 34601038
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

One hallmark feature of Parkinson's disease (PD) is Lewy body pathology associated with misfolded alpha-synuclein. Previous studies have shown that striatal injection of alpha-synuclein preformed fibrils (PFF) can induce misfolding and aggregation of native alpha-synuclein in a prion-like manner, leading to cell death and motor dysfunction in mouse models. Here, we tested whether alpha-synuclein PFFs injected into the medial prefrontal cortex results in deficits in interval timing, a cognitive task which is disrupted in human PD patients and in rodent models of PD. We injected PFF or monomers of human alpha-synuclein into the medial prefrontal cortex of mice pre-injected with adeno-associated virus (AAV) coding for overexpression of human alpha-synuclein or control protein. Despite notable medial prefrontal cortical synucleinopathy, we did not observe consistent deficits in fixed-interval timing. These results suggest that cortical alpha-synuclein does not reliably disrupt fixed-interval timing.

Citing Articles

Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing.

Bruce R, Weber M, Bova A, Volkman R, Jacobs C, Sivakumar K Elife. 2025; 13.

PMID: 39812105 PMC: 11735027. DOI: 10.7554/eLife.96287.


Cognitive dysfunction in animal models of human lewy-body dementia.

Haikal C, Winston G, Kaplitt M Front Aging Neurosci. 2024; 16:1369733.

PMID: 39104707 PMC: 11298446. DOI: 10.3389/fnagi.2024.1369733.


Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits.

Keomanivong C, Schamp J, Tabakovic E, Thangavel R, Aldridge G, Pieper A eNeuro. 2024; 11(2).

PMID: 38351057 PMC: 10866330. DOI: 10.1523/ENEURO.0170-23.2023.


Alpha-Synuclein Pre-Formed Fibrils Injected into Prefrontal Cortex Primarily Spread to Cortical and Subcortical Structures.

Weber M, Kerr G, Thangavel R, Conlon M, Gumusoglu S, Gupta K J Parkinsons Dis. 2024; 14(1):81-94.

PMID: 38189765 PMC: 10836574. DOI: 10.3233/JPD-230129.


Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.

Teil M, Dovero S, Bourdenx M, Arotcarena M, Darricau M, Porras G NPJ Parkinsons Dis. 2023; 9(1):135.

PMID: 37726343 PMC: 10509171. DOI: 10.1038/s41531-023-00579-w.


References
1.
Parker K, Chen K, Kingyon J, Cavanagh J, Narayanan N . Medial frontal ∼4-Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion. J Neurophysiol. 2015; 114(2):1310-20. PMC: 4588517. DOI: 10.1152/jn.00412.2015. View

2.
Fry W, Kelleher R, Cook L . A mathematical index of performance on fixed-interval schedules of reinforcement. J Exp Anal Behav. 1960; 3:193-9. PMC: 1404015. DOI: 10.1901/jeab.1960.3-193. View

3.
Luk K, Kehm V, Carroll J, Zhang B, OBrien P, Trojanowski J . Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012; 338(6109):949-53. PMC: 3552321. DOI: 10.1126/science.1227157. View

4.
Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

5.
Narayanan N, Land B, Solder J, Deisseroth K, DiLeone R . Prefrontal D1 dopamine signaling is required for temporal control. Proc Natl Acad Sci U S A. 2012; 109(50):20726-31. PMC: 3528521. DOI: 10.1073/pnas.1211258109. View